Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapy

Iwona Bojar 4  
Clinical Oncology Ward, St. John’s Cancer Center, Lublin, Poland
Department of Internal Medicine in Nursing, Medical University, Lublin, Poland
Department of Applied Psychology, Medical University, Lublin, Poland
Institute of Rural Health in Lublin, Poland
Ann Agric Environ Med 2015;22(4):724–730
Breast cancer is the most frequent malignant neoplasm in women. The evaluation of the quality of life has become a treatment parameter as important as survival.

The aim of the study was evaluation of the quality of life among women treated for breast cancer who underwent surgical procedures using two alternative methods: mastectomy or breast conserving therapy (BCT).

Material and Methods:
85 patients treated with BCT and 94 patients who underwent mastectomy were evaluated. Standard questionnaires for the evaluation of the quality of life of cancer patients were used – QLQ-C30 (Quality of life questionnaire – core 30) with QLQ-BR23 (Breast Cancer Module). The Hospital Anxiety and Depression Scale was also applied.

Social and demographic factors (age, education, marital status) influenced the evaluation of the life quality among both groups. Obtained data was also dependent on the type of surgical procedure and chemical treatment. The level of anxiety and depression also influenced the general quality of life and was higher in women who underwent mastectomy.

Quality of life plays an important role in the treatment process. Women after BCT declared a higher quality of life compared to patients after mastectomy. The process of making the decision concerning the planned surgical procedure should take into consideration the influence of the intervention on the quality of patients’ future life.

Iwona Bojar   
Institute of Rural Health in Lublin, Poland
1. Calonge N, Petitti DB, DeWitt TG, Dietrich AJ, Gregory KD, Grossman D. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151(10): 716–726.
2. Globocan 2008. Fast Stats. Most frequent cancers: women. Retrieved from: http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900#WOMEN (access: 2013.08.28).
3. Aebi S, Davidson T, Gruber G, Cardoso F. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011; 22(Supplement 6): vi 12-vi24.
4. Bishop H, Chan C, Monypenny I, Patnick J, Sibbering M, Watkins R, Winstanley J, Bundred N, Corder A, Nicholson S, Robertson J, Rothnie N, Davies L. Surgical guidelines for the management of breast cancer. Eur J Surg Oncol. 2009; 35(Suppl 1): 1–22.
5. WHOQOL Group. Study protocol for the World Health Organization. Project to develop a quality of life assessment instrument. Qual Life Res. 1993; 2(2): 153–159.
6. World Health Organization. Report of WHOQOL Focus Group Work. World Health Organization, 1993; Geneva.
7. Gotay CC, Moore TD. Assessing quality of life in head and neck cancer. Qual Life Res. 1992; 1(1): 5–17.
8. Honea NJ, Brintnall R, Given B, Sherwood P, Colao DB, Somers SC, Northouse LL. Putting evidence into practice: nursing assessment and interventions to reduce family caregiver strain and burden. Clin J Oncol Nurs. 2008; 12(3): 507–516.
9. Majkowicz M, Chojnacka-Szawłowska G. Metodologiczne problemy badania jakości życia. In: de Walden-Gałuszko, K., Majkowicz, M. Jakość życia w chorobie nowotworowej. Gdańsk, 1994; Wydawnictwo Uniwersytetu Gdańskiego (in Polish).
10. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality–of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5): 365–376.
11. Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996; 14(10): 2756–2568.
12. Zawisza K, Tobiasz-Adamczyk B, Nowak W, Kulig J, Jędrys J. Validity and reliability of the quality of life questionnaire (EORTC QLQ C30) and its breast cancer module (EORTC QLQ BR23). Ginekol Pol. 2010; 81(04): 262–267.
13. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67(6): 361–370.
14. Groenvold M. Health-related quality of life in early breast cancer. Dan Med Bull. 2010; 57(9): B4184.
15. Arndt V, Stegmaier C, Ziegler H, Brenner H. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study. J Cancer Res Clin Oncol. 2008; 134(12): 1311–1318.
16. Han J, Grothuesmann D, Neises M, Hille U, Hillemanns P. Quality of life and satisfaction after breast cancer operation. Arch Gynecol Obstet. 2010; 282(1): 75–82.
17. Maślach D, Krzyżak M, Szpak A, Bojar I, Bielska-Lasota M, Owoc A. The breast-conserving surgery of women with breast cancer in Podlaskie Voivodeship (Poland). Population study. Ann Agric Environ Med. 2013; 20(2): 395–400.
18. Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR. Quality of life at the end of primary treatment of breast cancer first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004; 96(5): 376–387.
19. Janz NK, Mujahid M, Lantz PM, Fagerlin A, Salem B, Morrow M, Deapen D, Katz SJ. Population based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer. Qual Life Res. 2005; 14(6): 1467–1479.
20. Pacian A, Kulik TB, Pacian J, Chruściel P, Żołnierczuk-Kieliszek D, Jarosz MJ. Psychosocial aspect of quality of life of Polish women with breast cancer. Ann Agric Environ Med. 2012; 19(3): 509–512.
21. Fobair P, Stewart SL, Chang S, D‘Onofrio C, Banks PJ, Bloom JR. Body image and sexual problems in young women with breast cancer. Psychooncology. 2006; 15(7): 579–594.
22. Waldman A, Pritzkuleit R, Raspe H, Katalinic A. The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res. 2007; 16(5): 767–776.
23. Ioannidis JP, Hesketh PJ, Lau J. Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: A meta-analysis of randomized evidence. J Clin Oncol. 2000; 18(19): 3409–3422.
24. Rietman JS, Dijkstra PU, Hoekstra HJ, Eisma WH, Szabo BG, Groothoff JW, Geertzen JH. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol. 2003; 29(3): 230–238.
25. Zegarski W, Głowacka I, Ostrowska Z. Ocena jakości życia kobiet po mastektomii na podstawie standardowych kwestionariuszy: QLQ-C30 i QLQ-BR23. Nowotwory. 2010; 60(6): 532–535.